BioCryst Pharmaceuticals Shares Outstanding 2006-2019 | BCRX

BioCryst Pharmaceuticals shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

BioCryst Pharmaceuticals Annual Shares Outstanding (Millions of Shares)
2018	103
2017	84
2016	74
2015	73
2014	67
2013	55
2012	49
2011	45
2010	45
2009	39
2008	38
2007	33
2006	29
2005	26

BioCryst Pharmaceuticals Quarterly Shares Outstanding (Millions of Shares)
Q2 2019	110
Q1 2019	110
Q4 2018	103
Q3 2018	105
Q2 2018	99
Q1 2018	99
Q4 2017	84
Q3 2017	84
Q2 2017	80
Q1 2017	75
Q4 2016	74
Q3 2016	74
Q2 2016	74
Q1 2016	74
Q4 2015	73
Q3 2015	73
Q2 2015	77
Q1 2015	72
Q4 2014	67
Q3 2014	72
Q2 2014	64
Q1 2014	60
Q4 2013	55
Q3 2013	57
Q2 2013	53
Q1 2013	51
Q4 2012	49
Q3 2012	51
Q2 2012	49
Q1 2012	47
Q4 2011	45
Q3 2011	45
Q2 2011	45
Q1 2011	45
Q4 2010	45
Q3 2010	45
Q2 2010	45
Q1 2010	44
Q4 2009	39
Q3 2009	38
Q2 2009	38
Q1 2009	38
Q4 2008	38
Q3 2008	38
Q2 2008	38
Q1 2008	38
Q4 2007	33
Q3 2007	34
Q2 2007	29
Q1 2007	29
Q4 2006	29
Q3 2006	29
Q2 2006	29
Q1 2006	29
Q4 2005	26
Q3 2005	26
Q2 2005	26
Q1 2005	24

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$0.285B	$0.021B
BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential commercialization including Fodosine in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life threatening influenza. BioCryst has a worldwide partnership with Roche for the development and commercialization BCX-4208, and is collaborating with Mundipharma for the development and commercialization of Fodosine in markets across Europe, Asia, Australia and certain neighboring countries.

Stock Name	Country	Market Cap	PE Ratio
Zoetis (ZTS)	United States	$59.064B	36.38
Takeda Pharmaceutical (TAK)	Japan	$26.341B	8.22
Astellas Pharma (ALPMY)	Japan	$26.215B	12.85
UCB SA (UCBJF)	Belgium	$15.008B	0.00
Grifols, S.A (GRFS)	Spain	$15.002B	19.14
Eisai (ESALY)	Japan	$14.332B	24.64
Merck (MKGAF)	Germany	$13.654B	18.63
Ionis Pharmaceuticals (IONS)	United States	$9.481B	20.45
Ono Pharmaceutical (OPHLF)	Japan	$9.383B	20.06
Neurocrine Biosciences (NBIX)	United States	$8.689B	0.00
IPSEN SA ADR (IPSEY)	France	$8.520B	0.00
Sage Therapeutics (SAGE)	United States	$8.318B	0.00
Catalent (CTLT)	United States	$8.054B	32.32
Jazz Pharmaceuticals (JAZZ)	Ireland	$7.439B	9.79
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF)	Italy	$7.257B	19.83
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$5.781B	0.00
STADA ARZNEIMI (STDAF)	Germany	$5.547B	0.00
Orion OYJ (ORINY)	Finland	$5.275B	27.16
Hypermarcas (HYPMY)	Brazil	$4.735B	17.02
FibroGen (FGEN)	United States	$3.750B	93.78
United Therapeutics (UTHR)	United States	$3.487B	0.00
Tilray (TLRY)	Canada	$3.415B	0.00
Nektar Therapeutics (NKTR)	United States	$3.188B	0.00
Evotec AG (EVTCY)	Germany	$3.120B	42.71
Taro Pharmaceutical Industries (TARO)	Israel	$3.103B	11.12
Arrowhead Pharmaceuticals (ARWR)	United States	$2.767B	63.44
PTC Therapeutics (PTCT)	United States	$2.614B	0.00
Xencor (XNCR)	United States	$2.284B	49.79
Portola Pharmaceuticals (PTLA)	United States	$2.085B	0.00
Zogenix (ZGNX)	United States	$2.057B	0.00
Pacira Pharmaceuticals (PCRX)	United States	$1.621B	59.00
CLINIGEN GP (CLIGF)	United Kingdom	$1.577B	0.00
USANA Health Sciences (USNA)	United States	$1.452B	14.56
Corcept Therapeutics (CORT)	United States	$1.439B	19.78
Ironwood Pharmaceuticals (IRWD)	United States	$1.404B	0.00
Enanta Pharmaceuticals (ENTA)	United States	$1.384B	22.84
Heron Therapeutics (HRTX)	United States	$1.349B	0.00
Theravance Biopharma (TBPH)	Cayman Islands	$1.205B	0.00
Aerie Pharmaceuticals (AERI)	United States	$1.129B	0.00
Radius Health (RDUS)	United States	$1.040B	0.00
ArQule (ARQL)	United States	$1.039B	0.00
Spectrum Pharmaceuticals (SPPI)	United States	$0.837B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$0.718B	3.20
TherapeuticsMD (TXMD)	United States	$0.716B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$0.552B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.545B	0.00
Concordia (CXRXF)	Canada	$0.533B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$0.518B	0.00
Akebia Therapeutics (AKBA)	United States	$0.511B	0.00
Endo (ENDP)	Ireland	$0.505B	0.89
Aptorum Group (APM)	China	$0.477B	0.00
Indivior (INVVY)	United States	$0.466B	1.68
Crinetics Pharmaceuticals (CRNX)	United States	$0.437B	0.00
Dermira (DERM)	United States	$0.430B	0.00
Dova Pharmaceuticals (DOVA)	United States	$0.427B	0.00
BioSpecifics Technologies Corp (BSTC)	United States	$0.421B	19.12
ImmunoGen (IMGN)	United States	$0.412B	0.00
Siga Technologies (SIGA)	United States	$0.411B	0.96
Flexion Therapeutics (FLXN)	United States	$0.409B	0.00
Translate Bio (TBIO)	United States	$0.405B	0.00
ChemoCentryx (CCXI)	United States	$0.376B	0.00
Innate Pharma SA (IPHYF)	France	$0.374B	0.00
Collegium Pharmaceutical (COLL)	United States	$0.366B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.354B	0.00
Organogenesis Holdings (ORGO)	United States	$0.326B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.322B	0.00
CV Sciences (CVSI)	United States	$0.317B	0.00
Xeris Pharmaceuticals (XERS)	United States	$0.292B	0.00
Harpoon Therapeutics (HARP)	United States	$0.286B	0.00
CannTrust Holdings (CTST)	Canada	$0.280B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.280B	0.00
Rafael Holdings (RFL)	United States	$0.269B	0.00
La Jolla Pharmaceutical (LJPC)	United States	$0.256B	0.00
Lannett Co Inc (LCI)	United States	$0.255B	2.48
DURECT (DRRX)	United States	$0.250B	0.00
OptiNose (OPTN)	United States	$0.249B	0.00
Concert Pharmaceuticals (CNCE)	United States	$0.244B	0.00
Recro Pharma (REPH)	United States	$0.241B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.219B	0.00
Calithera Biosciences (CALA)	United States	$0.210B	0.00
Ocular Therapeutix (OCUL)	United States	$0.199B	0.00
Molecular Templates (MTEM)	United States	$0.186B	0.00
Foamix Pharmaceuticals (FOMX)	Israel	$0.176B	0.00
AcelRx Pharmaceuticals (ACRX)	United States	$0.176B	0.00
Taiwan Liposome (TLC)	Taiwan	$0.175B	0.00
Nature's Sunshine Products (NATR)	United States	$0.174B	29.03
Redhill Biopharma (RDHL)	Israel	$0.147B	0.00
IMV INC (IMV)	Canada	$0.140B	0.00
Ardelyx (ARDX)	United States	$0.135B	0.00
GlycoMimetics (GLYC)	United States	$0.132B	0.00
Jounce Therapeutics (JNCE)	United States	$0.130B	0.00
Generex Biotechnology (GNBT)	United States	$0.128B	0.00
Majesco Entertainment (PTE)	United States	$0.119B	0.00
Oasmia Pharmaceutical AB (OASM)	Sweden	$0.117B	0.00
Matinas Biopharma Holdings (MTNB)	United States	$0.113B	0.00
ALLERGY THERAPT (AGYTF)	United Kingdom	$0.108B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.107B	0.00
MEI Pharma (MEIP)	United States	$0.106B	0.00
ASSERTIO THERAPEUTICS, INC (ASRT)	United States	$0.104B	0.00
Entasis Therapeutics Holdings (ETTX)	United States	$0.098B	0.00
AgeX Therapeutics (AGE)	United States	$0.098B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.094B	0.00
Mast Therapeutics (SVRA)	United States	$0.092B	0.00
Aquestive Therapeutics (AQST)	United States	$0.088B	0.00
Neos Therapeutics (NEOS)	United States	$0.088B	0.00
Cardiome Pharma (CORV)	Canada	$0.085B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.085B	32.41
Genocea Biosciences (GNCA)	United States	$0.082B	0.00
Natural Alternatives (NAII)	United States	$0.076B	7.62
RENEURON GP (RNUGF)	United Kingdom	$0.075B	0.00
MediWound (MDWD)	Israel	$0.074B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$0.074B	0.00
Nivalis Therapeutics (ALPN)	United States	$0.071B	0.00
Champions Oncology (CSBR)	United States	$0.069B	598.00
Infinity Pharmaceuticals (INFI)	United States	$0.068B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.068B	0.00
Otonomy (OTIC)	United States	$0.067B	0.00
Novan (NOVN)	United States	$0.065B	0.00
Adamis Pharmaceuticals (ADMP)	United States	$0.063B	0.00
Pharmaxis (PXSLY)	Australia	$0.060B	0.00
Opiant Pharmaceuticals (OPNT)	United States	$0.059B	0.00
SCYNEXIS (SCYX)	United States	$0.058B	0.00
Capnia (SLNO)	United States	$0.057B	0.00
Lipocine (LPCN)	United States	$0.053B	0.00
Medicure (MCUJF)	Canada	$0.053B	0.00
Dipexium Pharmaceuticals (PLXP)	United States	$0.053B	0.00
Bellicum Pharmaceuticals (BLCM)	United States	$0.046B	0.00
ElectroCore (ECOR)	United States	$0.045B	0.00
Forward Pharma (FWP)	Denmark	$0.044B	0.00
India Globalization Capital (IGC)	United States	$0.040B	0.00
CTI BioPharma (CTIC)	United States	$0.038B	0.00
Mannatechorporated (MTEX)	United States	$0.036B	0.00
Bio-Path Holdings (BPTH)	United States	$0.035B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.033B	0.00
Melinta Therapeutics (MLNT)	United States	$0.032B	0.00
PharmAthene (ALT)	United States	$0.032B	0.00
Biomerica (BMRA)	United States	$0.030B	0.00
ProPhase Labs (PRPH)	United States	$0.023B	0.00
IsoRay (ISR)	United States	$0.021B	0.00
Opexa Therapeutics (ACER)	United States	$0.020B	0.00
Heat Biologics (HTBX)	United States	$0.019B	0.00
Summit Therapeutics (SMMT)	United Kingdom	$0.018B	1.43
HANCOCK JAFFE (HJLI)	United States	$0.017B	0.00
NovaBay Pharmaceuticals (NBY)	United States	$0.015B	0.00
Tetraphase Pharmaceuticals (TTPH)	United States	$0.015B	0.00
Achieve Life Sciences (ACHV)	United States	$0.014B	0.00
Cyanotech (CYAN)	United States	$0.014B	0.00
Onconova Therapeutics (ONTX)	United States	$0.014B	0.00
Shineco (TYHT)	China	$0.013B	0.00
Regulus Therapeutics (RGLS)	United States	$0.012B	0.00
Kitov Pharmaceuticals Holdings (KTOV)	Israel	$0.011B	0.00
VAXART, INC (VXRT)	United States	$0.010B	0.00
Eyegate Pharmaceuticals (EYEG)	United States	$0.009B	0.00
RXi Pharmaceuticals (PHIO)	United States	$0.009B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.007B	0.00
Jaguar Animal Health (JAGX)	United States	$0.006B	0.00
Flex Pharma (SLRX)	United States	$0.004B	0.00
Midatech Pharma (MTP)	United Kingdom	$0.004B	0.00
Can-Fite Biopharma (CANF)	Israel	$0.003B	0.00
Cytori Therapeutics Inc (PSTV)	United States	$0.002B	0.00
Xenetic Biosciences (XBIO)	United States	$0.001B	0.00
Advanced Accelerator Applications S.A (AAAP)	France	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00